Star Therapeutics
Star Therapeutics raises $125M Series D
Quick Facts
Star Therapeutics: Series D Funding Round
Star Therapeutics has successfully raised $125M in Series D funding.
Company Overview
Developing antibody therapies for autoimmune and inflammatory diseases
Funding Details
The Series D round was led by Sanofi Ventures, with participation from Viking Global Investors.
Company Information
- Headquarters: South San Francisco, CA
- Founded: 2016
- Employees: 180+
- Category: HealthTech
Investment
Star Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sanofi Ventures: Verified investor in Series D
- Viking Global Investors: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
